UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4410-4416

2011

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3100-3109

2013

Link zum Volltext

Verfügbarkeit prüfen

Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma

Journal of clinical oncology, 2010-08, Vol.28 (23), p.e404-e405

Suzuki, Ritsuro

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4626-4633

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

Journal of clinical oncology, 2017-01, Vol.35 (1), p.32-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type

Journal of clinical oncology, 2010-05, Vol.28 (14), p.e229; author reply e230-e229

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7565-7565

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7551-7551

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of FOLFIRINOX with PEG-G-CSF for unresectable/recurrent pancreatic cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.411-411

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I fixed-dose feasibility study of MK615 and gemcitabine in patients with advanced or metastatic pancreatic cancer

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.510-510

2018

Link zum Volltext

Verfügbarkeit prüfen

Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7546-7546

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7541-7541

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply to A. Chan et al

Journal of clinical oncology, 2012-03, Vol.30 (9), p.1016-1017

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of donor source on allogeneic stem cell transplantation for Philadelphia chromosome-negative acute lymphoblastic leukemia

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6533-6533

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

Zeitschrift / SerieJournal Of Clinical Oncology

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type

Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan

Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL)

Effect of FOLFIRINOX with PEG-G-CSF for unresectable/recurrent pancreatic cancer

A phase I fixed-dose feasibility study of MK615 and gemcitabine in patients with advanced or metastatic pancreatic cancer

Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)

Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan

Reply to A. Chan et al

Impact of donor source on allogeneic stem cell transplantation for Philadelphia chromosome-negative acute lymphoblastic leukemia

Aktive Filter

Suchergebnisse filtern